Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients

Mise à jour : Il y a 4 ans
Référence : NCT00635765

Femme et Homme

Extrait

The purpose of this study is to assess the safety profile of C2L-OCT-01 PR for up to an additional 96-week period in acromegalic patients who completed the C2L-OCT-01 PR-301 study.


Critère d'inclusion

  • Acromegaly


Liens